Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections deliver glucagon-like peptide-1 (GLP-1) agonist therapy through subcutaneous administration, and understanding proper injection site selection directly impacts both comfort and treatment effectiveness. Many patients wonder whether they can inject above the navel, and the answer is yes—with specific anatomical guidelines. PlexusDx compounded semaglutide follows the same injection site recommendations as branded formulations, allowing flexibility while maintaining safety.
Approved Semaglutide Injection Sites Above the Navel
The abdomen remains the most common injection location for semaglutide, and patients can safely inject in the upper abdominal area above the belly button. The preferred zone extends from below the rib cage down to approximately one inch above the navel, avoiding the area directly around the umbilicus. This upper abdominal region typically has sufficient subcutaneous tissue to accommodate the needle depth required for proper GLP-1 receptor engagement in the adipose layer.
Beyond the abdomen, semaglutide can also be injected into the outer thigh (anterior and lateral surfaces) and the back of the upper arm (deltoid region). These alternative sites offer patients flexibility, particularly those who struggle with abdominal injections or prefer to rotate between multiple locations. Each injection site should be separated by at least one to two inches from the previous injection to minimize tissue damage and reduce the risk of lipohypertrophy, a thickening of subcutaneous fat that can develop with repeated injections in identical spots.
Why Proper Injection Site Rotation Matters for Medication Absorption
Rotating injection sites across multiple approved locations—upper abdomen, thigh, and upper arm—ensures consistent and predictable semaglutide absorption. The subcutaneous tissue in each body region has slightly different blood flow patterns and fat density, meaning that using the same spot repeatedly may alter how quickly the medication enters the bloodstream. Clinical evidence suggests that consistent absorption leads to more stable appetite suppression and improved weight loss outcomes over the 12-week and beyond treatment windows.
When patients repeatedly inject into the same location, they risk developing injection site complications including lipohypertrophy, lipoatrophy (fat loss), and localized inflammation. These changes can create pockets of scar tissue that absorb medication unpredictably, potentially reducing efficacy. PlexusDx recommends maintaining a simple rotation schedule—for example, alternating between right and left upper abdomen one week, then moving to thigh injections the following week—to distribute the burden evenly across tissues and maintain predictable pharmacokinetics.
Step-by-Step Technique for Safe Upper Abdominal Injections
Prepare the injection site by cleaning the skin with an alcohol swab and allowing it to air dry completely; this reduces bacterial contamination and ensures the needle penetrates cleanly. Pinch a fold of skin and subcutaneous fat between your thumb and forefinger, creating a tent that elevates the adipose layer away from muscle tissue below. Insert the needle at a 90-degree angle (perpendicular to the skin) into the center of the pinched area, then slowly depress the plunger to deliver semaglutide over several seconds rather than rapidly.
After injection, remove the needle in the same direction it entered, and gently release the skin fold without rubbing or massaging the site. You may apply light pressure with a clean gauze pad for a few seconds if needed, but avoid aggressive massage, which can disperse medication into surrounding tissue. Allow the injection site to air dry, and wait at least 15 minutes before dressing or applying topical products. If you experience significant pain, swelling, or redness that persists beyond two hours, contact your healthcare provider to rule out infection or allergic reaction.
PlexusDx Compounded Semaglutide and Personalized Dosing Guidance
PlexusDx compounds semaglutide in a licensed 503A pharmacy, matching the same active ingredient and delivery mechanism as name-brand formulations while offering flexible dosing without membership fees or insurance requirements. Compounded semaglutide injections start at $149 per month, with your dose potentially increasing during treatment while your monthly price remains flat—a key difference that allows for dose optimization without financial penalty. The medication comes with detailed patient instructions that align with standard subcutaneous injection best practices, ensuring safety across all approved anatomical sites.
For patients interested in understanding their individual response to GLP-1 therapy, PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after the first month of treatment. This peptide-pathway genetic assessment maps 14 metabolic pathways and analyzes 150+ genetic insights, including variants in the GLP1R gene (rs6923761), GIPR pathway (rs1800437), and appetite-regulation genes like MC4R (rs17782313). This personalization helps identify whether your body's peptide pathways favor semaglutide monotherapy or might benefit from dual-compound options like GLP-Squared, ensuring your injection regimen aligns with your genetic predisposition.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide above my belly button every week?
Yes, you can inject above the navel in the upper abdominal region on a weekly schedule, provided you rotate sites within that zone and avoid injecting in the identical spot repeatedly. Rotating between the upper abdomen, thigh, and upper arm across different weeks prevents lipohypertrophy and maintains consistent medication absorption. PlexusDx semaglutide is dosed once weekly, and site rotation is built into this schedule to optimize outcomes.
What is the exact distance between injection sites to prevent complications?
Space each injection at least one to two inches away from the previous injection site to minimize tissue trauma and reduce the risk of lipohypertrophy and lipoatrophy. This distance allows the subcutaneous tissue time to recover between punctures. Over a 12-week treatment course, rotating across multiple approved sites—abdomen (both upper and lower regions), thighs, and upper arms—provides sufficient spacing for safe, consecutive weekly injections.
Does PlexusDx compounded semaglutide work the same as branded Ozempic or Wegovy?
PlexusDx compounded semaglutide contains the same active GLP-1 agonist ingredient as branded formulations and is prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and potency. The injection technique and site recommendations are identical across all semaglutide products. PlexusDx pricing starts at $149 per month with no insurance required, and your price stays flat even as your dose increases.
What should I do if my injection site becomes swollen or inflamed?
Minor redness and swelling at the injection site within one to two hours is normal and typically resolves on its own; apply a cool compress if discomfort persists. However, if swelling, redness, warmth, or pain continues beyond two hours, spreads beyond the immediate injection area, or is accompanied by fever or drainage, contact your healthcare provider immediately to rule out infection or allergic reaction. Switch to a different injection site for your next dose while the affected area heals.
Could the Precision Peptide Genetic Test help optimize my semaglutide injection strategy?
The PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 peptide pathways and 150+ insights, including GLP1R variants that influence how your body responds to semaglutide therapy. If testing reveals that your genetic profile favors enhanced GLP-1 signaling, your current injection regimen and dose may be well-matched; if other pathways show stronger engagement, a dual-compound option like GLP-Squared might optimize your results. The test costs $99 as an add-on after your first month of treatment and provides actionable data for personalized therapy planning.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Give Yourself an Injection of Semaglutide: A Comprehensive Guide
Do You Lose Fat or Muscle on Ozempic? Understanding Body Composition During Weight Loss